6" (15 cm) Appx 0.26 ml, Smallbore Ext Set w/Clamp, NanoClave T-Connector, Rotating Luer; 1 unit per pouch, 50 multivac pouches per case; UDI:(01)10887709051024(17)250101(30)50(10)4603240;(01)10887709051024(17)250201(30)50(10)4714349; (01)10887709051024(17)250201(30)50(10)4733540; (01)10887709051024(17)250201(30)50(10)4724812; (01)10887709051024(17)241201(30)50(10)4515226; (01)10887709051024(17)241201(30)50(10)4537113; (01)10887709051024(17)250101(30)50(10)4557474; (01)10887709051024(17)250201(30)50(10)4718500; (01)10887709052793(17)250101(30)50(10)4557476; (01)10887709052793(17)250101(30)50(10)4590957; The Intravascular Administration Set is a single use, sterile, non-pyrogenic device which provides access for the administration of fluids from a container to a patient's vascular system through the administration set's needle or catheter (which is inserted into a vein).
Published October 28, 2020 · Recall initiated: July 6, 2020
Summary
FDA records medical device Class II recall Z-0183-2021, published October 28, 2020 and initiated July 6, 2020. Recalling firm: ICU Medical, Inc.; Status: Terminated; Reported quantity: Total of all products (Listed #1 thru 101) = 304735 units; Lot: Lot Numbers: 4603240, 4714349,4733540,4724812, 4515226, 4537113, 4557474, 4718500, 4557476,4590957. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Identification of a potential manufacturing defect on the internal surface of the NanoClave within specific lots of NanoClave sets, which may inhibit a proper seal with the NanoClave spike.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ICU Medical, Inc.
- Distributor
- Worldwide Distribution: US (nationwide): AL, AZ, CA, CO, DE, FL,GA,ID, IL,IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NH,NJ,NM,NV, NY, OH, OK, OR, PA,RI, TN, TX, UT, VA, WA, WI, and WV; and OUS countries of: Belgium, Brazil, Canada, France, Germany, Ireland, Japan, Martinique, Mexico, Poland, and Saudi Arabia.
- Lot
- Lot Numbers: 4603240, 4714349,4733540,4724812, 4515226, 4537113, 4557474, 4718500, 4557476,4590957.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAIV Sets with drip chambersSeptember 23, 2026
- FDAIV Sets with drip chambersSeptember 23, 2026
- FDAOncology sets with drip chambersSeptember 23, 2026
- FDAIV Non-Dedicated Gravity Administration Sets with drip chambersSeptember 23, 2026
- FDABien-Air Surgery REF 1600517-001 SN ******* MULTIFUNCTION PEDAL OSSEODUO - Product Usage: Product Usage:October 28, 2020
- FDA5 IN(13cm) APPX 0.87ml, EXT SET,NanoClave T-CONNECTOR; 1 unit per pouch, 50 pouches per case; UDI:October 28, 2020
Questions about this recall
Was 6" (15 cm) Appx 0.26 ml, Smallbore Ext Set w/Clamp, NanoClave T-Connector, Rotating Luer; 1 unit per pouch, 50 multivac pouches per case; UDI:(01)10887709051024(17)250101(30)50(10)4603240;(01)10887709051024(17)250201(30)50(10)4714349; (01)10887709051024(17)250201(30)50(10)4733540; (01)10887709051024(17)250201(30)50(10)4724812; (01)10887709051024(17)241201(30)50(10)4515226; (01)10887709051024(17)241201(30)50(10)4537113; (01)10887709051024(17)250101(30)50(10)4557474; (01)10887709051024(17)250201(30)50(10)4718500; (01)10887709052793(17)250101(30)50(10)4557476; (01)10887709052793(17)250101(30)50(10)4590957; The Intravascular Administration Set is a single use, sterile, non-pyrogenic device which provides access for the administration of fluids from a container to a patient's vascular system through the administration set's needle or catheter (which is inserted into a vein). recalled?
Yes. FDA published recall Z-0183-2021 on October 28, 2020. Reported hazard: Identification of a potential manufacturing defect on the internal surface of the NanoClave within specific lots of NanoClave sets, which may inhibit a proper seal with the NanoClave spike.
What should I do if I have this product?
Voluntary: Firm initiated · Letter